Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors

Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors

Abstract With the widespread use of immune checkpoint inhibitors (ICIs), identifying predictive biomarkers is critical. Recently, serum fucosylated haptoglobin (Fuc-Hp) was thought to play an important role in tumour immunity in several types of cancer. Therefore, evaluating serum Fuc-Hp in the peri...

Full description

Bibliographic Details
Main Authors:	Taigo Kato, Koichi Morishita, Eisuke Tomiyama, Ayumu Hayashibara, Yu Ishizuya, Yoshiyuki Yamamoto, Koji Hatano, Atsunari Kawashima, Shinichiro Fukuhara, Norio Nonomura, Eiji Miyoshi, Kazutoshi Fujita
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-10-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-42739-1

Similar Items

Fucosylation in Urological Cancers
by: Kazutoshi Fujita, et al.
Published: (2021-12-01)

Transcription factor SP1 regulates haptoglobin fucosylation via induction of GDP-fucose transporter 1 in the hepatoma cell line HepG2
by: Jumpei Kondo, et al.
Published: (2022-12-01)

A case of retroperitoneal liposarcoma extending through the inguinal canal to the thigh and lesser trochanter
by: Takahiro Maekawa, et al.
Published: (2023-07-01)

A retroperitoneal primary undifferentiated pleomorphic sarcoma
by: Makishi Nakamura, et al.
Published: (2024-03-01)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
by: Fumie Yoshioka, et al.
Published: (2023-03-01)

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
by: Taigo Kato, et al.
Published: (2021-01-01)

Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression
by: Hyewon Choi, et al.
Published: (2023-04-01)

Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma
by: Yuki Nishimura, et al.
Published: (2023-03-01)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
by: Yujiro Hayashi, et al.
Published: (2020-10-01)

Mucinous cystadenoma of the renal parenchyma presenting as a Bosniak IIF complex renal cyst
by: Takanori Nate, et al.
Published: (2023-03-01)

Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
by: Yoshihiro Kamada, et al.
Published: (2013-01-01)

Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
by: Akinaru Yamamoto, et al.
Published: (2022-04-01)

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report
by: Tetsuya Yamamoto, et al.
Published: (2021-05-01)

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
by: Yujiro Hayashi, et al.
Published: (2020-05-01)

Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
by: Yujiro Hayashi, et al.
Published: (2022-10-01)

Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
by: Toshihiro Uemura, et al.
Published: (2023-09-01)

Mutational Landscape and Environmental Effects in Bladder Cancer
by: Takuji Hayashi, et al.
Published: (2020-08-01)

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
by: Seiichi Tawara, et al.
Published: (2016-01-01)

Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
by: Yoko Maegawa, et al.
Published: (2020-09-01)

Trop-2 in Upper Tract Urothelial Carcinoma
by: Eisuke Tomiyama, et al.
Published: (2022-05-01)

Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis.
by: Kumiko Shirai, et al.
Published: (2022-01-01)

Application of Anti-Inflammatory Agents in Prostate Cancer
by: Koji Hatano, et al.
Published: (2020-08-01)

Durable response of chemotherapy for cancer of unknown primary with unfavorable subset developed in retroperitoneal space
by: Atsuki Matsukawa, et al.
Published: (2021-07-01)

Selective arterial embolization for uncontrollable urethral hemorrhage in a patient with a left ventricular assist device
by: Yujiro Hayashi, et al.
Published: (2018-03-01)

Erectile Dysfunction in Germ Cell Tumor Survivors
by: Koichi Okada, et al.
Published: (2021-07-01)

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
by: Eisuke Tomiyama, et al.
Published: (2020-07-01)

EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
by: Mototaka Sato, et al.
Published: (2013-01-01)

Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy
by: Shinichiro Shinzaki, et al.
Published: (2012-01-01)

Editorial Comment from Dr Fukuhara and Dr Nonomura to A case of hypogonadtropic hypogonadism due to hypophysitisdiscovered by secondary male infertility
by: Shinichiro Fukuhara, et al.
Published: (2023-01-01)

Role of Androgen Receptor in Prostate Cancer: A Review
by: Kazutoshi Fujita, et al.
Published: (2019-09-01)

A case of mediastinal teratoma with malignant transformation into angiosarcoma and relapse with multiple bone metastases that was cured by a multidisciplinary treatment
by: Masaru Tani, et al.
Published: (2023-03-01)

Localization and potential role of prostate microbiota
by: Koichi Okada, et al.
Published: (2022-12-01)

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma.
by: Kyosuke Matsuzaki, et al.
Published: (2018-01-01)

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
by: Takuji Hayashi, et al.
Published: (2019-08-01)

Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage
by: Spiros L. Blackburn, et al.
Published: (2018-05-01)

Role of Fucosylation in Cancer
by: Kun ZHANG, et al.
Published: (2016-11-01)

Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review
by: Koji Hatano, et al.
Published: (2023-10-01)

Genomic Profiling of Prostate Cancer: An Updated Review
by: Koji Hatano, et al.
Published: (2022-07-01)

Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer
by: Yoshiyuki Yamamoto, MD, PhD, et al.
Published: (2023-05-01)

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
by: Kazutoshi Fujita, et al.
Published: (2023-02-01)